IL85164A0 - Pharmaceutical parenteral solutions - Google Patents

Pharmaceutical parenteral solutions

Info

Publication number
IL85164A0
IL85164A0 IL85164A IL8516488A IL85164A0 IL 85164 A0 IL85164 A0 IL 85164A0 IL 85164 A IL85164 A IL 85164A IL 8516488 A IL8516488 A IL 8516488A IL 85164 A0 IL85164 A0 IL 85164A0
Authority
IL
Israel
Prior art keywords
parenteral solutions
pharmaceutical parenteral
pharmaceutical
solutions
parenteral
Prior art date
Application number
IL85164A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL85164A0 publication Critical patent/IL85164A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
IL85164A 1987-01-24 1988-01-21 Pharmaceutical parenteral solutions IL85164A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873702105 DE3702105A1 (de) 1987-01-24 1987-01-24 Parenterale loesung

Publications (1)

Publication Number Publication Date
IL85164A0 true IL85164A0 (en) 1988-07-31

Family

ID=6319487

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85164A IL85164A0 (en) 1987-01-24 1988-01-21 Pharmaceutical parenteral solutions

Country Status (10)

Country Link
US (1) US4842856A (ja)
EP (1) EP0276674A1 (ja)
JP (1) JPS63192714A (ja)
KR (1) KR880008801A (ja)
AU (1) AU597139B2 (ja)
DE (1) DE3702105A1 (ja)
HU (1) HU198381B (ja)
IL (1) IL85164A0 (ja)
NZ (1) NZ223253A (ja)
ZA (1) ZA88442B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2650502B1 (fr) * 1989-08-07 1994-05-27 Delagrange Laboratoires Nouvelle forme galenique orale ameliorant la biodisponibilite
DE69226197T2 (de) * 1991-11-08 1999-02-11 Somatogen Inc Hämoglobine als arzneimittelabgabesystem
HUP9701554D0 (en) 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
AU2530700A (en) * 1999-02-11 2000-08-29 Kinetana Inc. Serum albumin-based parenteral formulations of polyene macrolides
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
WO2005025507A2 (en) * 2003-09-10 2005-03-24 Synta Phamaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
JPWO2009116557A1 (ja) * 2008-03-21 2011-07-21 富士フイルム株式会社 薬剤含有組成物
US20150140040A1 (en) * 2010-01-19 2015-05-21 Robert E. Coifman Methods of depositing particles of a substance in a tissue
NZ613167A (en) 2010-12-16 2015-09-25 Univ Texas Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
PL2701684T3 (pl) 2011-04-28 2018-09-28 Platform Brightworks Two, Ltd. Ulepszone preparaty pozajelitowe lipofilowych środków farmaceutycznych oraz sposoby ich wytwarzania i stosowania
CN107412783B (zh) 2017-04-28 2020-09-22 中国人民解放军军事医学科学院毒物药物研究所 一种包裹有难溶于水药物的蛋白质颗粒的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE427669C (de) * 1922-10-27 1926-04-14 Merck Ag E Verfahren zur Darstellung eines kolloidalen, in Wasser loeslichen Wismutes fuer Injektionszwecke
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4499073A (en) * 1981-08-24 1985-02-12 Cutter Laboratories, Inc. Intravenously injectable immune serum globulin
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
DE3316510A1 (de) * 1983-05-06 1984-11-08 Bayer Ag Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0140255B1 (en) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation

Also Published As

Publication number Publication date
AU597139B2 (en) 1990-05-24
NZ223253A (en) 1990-08-28
ZA88442B (en) 1988-07-22
HU198381B (en) 1989-10-30
EP0276674A1 (de) 1988-08-03
JPS63192714A (ja) 1988-08-10
US4842856A (en) 1989-06-27
DE3702105A1 (de) 1988-08-04
KR880008801A (ko) 1988-09-13
HUT47838A (en) 1989-04-28
AU1032388A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
CS403391A3 (en) Pharmaceutical
GR3002864T3 (en) Azolylmethylcyclopropyl derivatives
GB2206308B (en) Web-steering mechanisms
IL85164A0 (en) Pharmaceutical parenteral solutions
GB8815258D0 (en) Thiorea derivatives
EP0318704A3 (en) 3-cyano-4-phenyl-pyrrole derivatives
ZA898323B (en) Pharmaceutical solution
EP0305322A3 (en) Isoxazole-beta-carboline derivatives
GR3000964T3 (en) Hydroxyethyl-azolyl derivatives
GB2205829B (en) 2-aryl-4-isoxazolin-3-one derivatives
GB8705601D0 (en) Oxo-isoindolinyl derivatives
EP0322164A3 (en) Ethanolamie derivatives
GB8726272D0 (en) 4-demethoxy anthra-cycline derivatives
GB2200910B (en) Thiopilocarpine derivatives
GB8704236D0 (en) Anthracycline-oestrone derivatives
GB8715594D0 (en) Line spacing mechanisms
GB8700016D0 (en) Quinolizinone derivatives
PL263661A1 (en) Can
GB8715925D0 (en) Thiapentanamide derivatives
RO101663B1 (en) Anti-hemorroidal medication
GB2211840B (en) Indenofuran derivatives
AU101896S (en) Tablet
AU101897S (en) Tablet
BG46772A1 (en) Antiulcer drug
RO101174B1 (en) Antiulcer drug